TrialThe oncologist2020

The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407).

Enrique Grande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.